Sort
85,873 grants matching “alzheimers”
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial
$1,039,233Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2024 · AG
UAMS Alzheimer's Disease Core Center
$1,039,181University Of Arkansas Med Scis Ltl Rock · P30 · FY2005 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,038,959John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
ARIC Neurocognitive Study (ARIC-NCS)
$1,038,919Alvaro Alonso · University Of Minnesota · U01 · FY2010 · HL
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults
$1,038,541Rhoda Au · Boston University Medical Campus · R01 · FY2017 · AG
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$1,038,413Michael D Geschwind · University Of California, San Francisco · R01 · FY2020 · AG
Risk for Alzheimer's Disease and Cognitive Decline in Project TALENT
$1,038,403Carol A. Prescott · University Of Southern California · R01 · FY2017 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,037,676Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2019 · AG
Virus and olfactory system interactions accelerate Alzheimer's disease pathology
$1,037,518Diego Restrepo · University Of Colorado Denver · R01 · FY2023 · AG
CEREBRAL AMYLOID ANGIOPATHY AND MECHANISMS OF BRAIN AMYLOID ACCUMULATION
$1,037,212Steven M Greenberg · Massachusetts General Hospital · R01 · FY2016 · NS
Genomic regulation of immune response in neurodegeneration in mice
$1,036,314Han-Yu Shih · National Eye Institute · ZIA · FY2021 · EY
Role of Microglia somatic variants in Neurodegenerative diseases
$1,036,170Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2022 · NS
Role of Microglia somatic variants in Neurodegenerative diseases
$1,036,170Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2021 · NS
High-performance compact 3T MRI: Technical optimization for advanced brain imaging
$1,036,002Matthew A. Bernstein · Mayo Clinic Rochester · U01 · FY2020 · EB
Brain atrophy, cognitive impairment and Alzheimer's in low CVD-risk population
$1,035,885Hillard S Kaplan · Chapman University · RF1 · FY2020 · AG
Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy
$1,035,811Graham Beaton · Epigen Biosciences, Inc. · R44 · FY2021 · DK
CALCIUM REGULATION IN BRAIN AGING AND ALZHEIMERS DISEASE
$1,035,800University Of Kentucky · P01 · FY2000 · AG
Research Core- The State Alzheimer's Research Support Center (StARS)
$1,035,719Philip D Sloane · University Of Minnesota · U54 · FY2024 · AG
Racial/Ethnic Disparities in ADRD Risk: The Impact of Social Relations-Administrative Supplement for Increased Costs
$1,035,606Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2023 · AG
MICHIGAN ALZHEIMERS DISEASE RESEARCH CENTER
$1,035,000University Of Michigan At Ann Arbor · P50 · FY2004 · AG
Identifying Mechanisms of Dementia: Role for MRI in the Era of Molecular Imaging
$1,034,999Clifford Jack · Mayo Clinic Rochester · R01 · FY2010 · AG
Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS
$1,034,893Terrie F Wetle · Brown University · R01 · FY2020 · AG
EPIDEMIOLOGY OF DEMENTIA IN OLDER JAPANESE AMERICANS
$1,034,714University Of Washington · R01 · FY2000 · AG
National Resource For Advanced NMR Technology
$1,034,604Timothy A Cross · Florida State University · P41 · FY2020 · GM
National Resource For Advanced NMR Technology
$1,034,604Timothy A Cross · Florida State University · P41 · FY2019 · GM